BCI in The Times Pancreatic Cancer Supplement
The Times Raconteur supplement on Pancreatic Cancer, 3 Nov 11
BCI researchers featured heavily in the Pancreatic Cancer supplement which accompanied Thursday's edition of The Times (3 November 2011).
The supplement, commissioned by the Pancreatic Cancer Research Fund (PCRF), featured several of our PhD students (Sabari Vallath, Kate Lines, Constantia Pantelidou, Stacey Coleman), as well as an interview with Professor Nick Lemoine.
Pancreatic cancer has the lowest survival rate of all cancers – just 3% of those diagnosed survive for five years.